A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis
Clinical trial NCT03129100 · COMPLETED
Trial details
- NCT number
- NCT03129100
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-09
- Primary completion
- 2020-05-26
- Enrollment
- 773
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.